is bpc 157 banned by wada WADA just added tirzepatide (mounjaro) to the 2026 Monitoring Program BPC-157 for athletes and injury
Description
The corresponding test reports including test codes are publicly accessible
IGF-1 LR3 remains an agonist of the IGF-1 receptor, but it has very low affinity for IGFBPs, which inhibit IGF-1, making it more potent
demonstrates that pituitary-level GH stimulation translates to skeletal outcomes at the tissue level Limitations : Rodent models only
These situations warrant pausing: Severe, persistent vomiting that prevents adequate hydration for more than 48 hours
